Rhinosinusitis in children with acute respiratory infection: quality of life and features of drug therapy

Abstract

BACKGROUND: The relevance of the study is due to limited information on the impact of various forms of rhinosinusitis that have arisen against the background of acute respiratory infection on the quality of life of children and effective treatment methods.

AIM: To conduct a clinical assessment of the effect on the recovery time and quality of life in children with acute rhinosinusitis and exacerbation of polypous rhinosinusitis that occurred against the background of a respiratory infection, including antiviral drugs in complex treatment in the early stages.

MATERIALS AND METHODS: A simple controlled randomized comparative clinical trial was conducted, involving 74 children aged 15 to 18 years. The clinical efficacy and safety of the use of antiviral drugs in complex therapy, which are neuraminidase inhibitors on the 5^th, 7^th and 10^th days of treatment, were evaluated in comparison with groups receiving pentanedioic acid imidazolylethanamide. The inclusion criterion was acute rhinosinusitis and exacerbation of chronic polypous rhinosinusitis against the background of acute respiratory infection. To establish the diagnosis, an examination of ENT organs, computed tomography of the nose and paranasal sinuses were performed, patients subjectively assessed clinical complaints and quality of life in the Russian version of the standard form of the SF-36 questionnaire.

RESULTS: Positive dynamics was noted in the early stages in the 2^nd subgroup of the 1^st group who took neuraminidase inhibitors in addition to complex therapy. Manifested by a decrease in the average score for VAS to 80.0%, difficulty in nasal breathing to 1.7 points on the 10^th day of treatment, relative to those taking imidazolylethanamide pentanedioic acid, where there was a decrease in the average score for VAS by 22.4%, difficulty in nasal breathing to 2.54 points. A similar pattern was observed with nasal congestion, rhinorrhea, and quality of life indicators according to the SF-36 questionnaires.

CONCLUSION: Improvement of clinical symptoms and quality of life indicators at an earlier date in children with polypous rhinosinusitis and acute rhinosinusitis against the background of a previous respiratory infection with the inclusion of neuraminidase inhibitors in complex therapy confirmed higher efficacy.

Keywords

acute rhinosinusitis / polypous rhinosinusitis / acute respiratory infections / quality of life / antiviral therapy

References

[1] Bogomilsky MR, editor. Diseases of the ear, throat and nose in childhood. National Leadership. Moscow: GEOTAR-Мedia; 2021. (In Russ).

[2] Болезни уха, горла и носа в детском возрасте. Национальное руководство / под ред. М.Р. Богомильского. Москва: ГЭОТАР-Медиа, 2021.

[3] Geppe NA, Karpova EP, Tulupov DA, et al. The consensus of resolution on nasal obstruction in children 0 to 3 years old. Clinical Practice in Pediatrics. 2023;18(1):144–152. EDN: RBFXGP doi: 10.20953/1817-7646-2023-1-144-152

[4] Геппе Н.А., Карпова Е.П., Тулупов Д.А., и др. Резолюция консенсуса по назальной обструкции у детей от 0 до 3 лет // Вопросы практической педиатрии. 2023. Т. 18, № 1. С. 144–152. EDN: RBFXGP doi: 10.20953/1817-7646-2023-1-144-152

[5] Clinical recommendations — Acute sinusitis — 2021-2022-2023 (01.09.2021). Approved by the Ministry of Health of the Russian Federation [Internet]. [cited: 2023 Nov 25]. Available from: https://gbpokachi.ru/upload/medialibrary/9f1/h1jommyg1xipgocbclzi80y7tguodaql.pdf (In Russ).

[6] Клинические рекомендации — Острый синусит — 2021-2022-2023 (01.09.2021). Утверждены Минздравом РФ [интернет]. Дата обращения: 25.11.2023. Режим доступа: https://gbpokachi.ru/upload/medialibrary/9f1/h1jommyg1xipgocbclzi80y7tguodaql.pdf

[7] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2000;58 Suppl. S29: 1–464. doi: 10.4193/Rhin20.600

[8] Fokkens W.J., Lund V.J., Hopkins C., et al. European position paper on rhinosinusitis and nasal polyps // Rhinology. 2000. Vol. 58, Suppl. S29. P. 1–464. doi: 10.4193/Rhin20.600

[9] Russian Society of Rhinologists. Updated clinical recommendations of the Russian Society of Rhinologists “acute rhinosinusitis” [Internet]. [cited: 2023 Jan 12]. Available from: http://rhinology.ru/2021/09/15/obnovlennye-klinicheskie-rekomendacii-rossijskogo-obshhestva-rinologov-ostryj-rinosinusit/

[10] Российское общество ринологов. Обновленные клинические рекомендации российского общества ринологов «острый риносинусит» [интернет]. Режим доступа: http://rhinology.ru/2021/09/15/obnovlennye-klinicheskie-rekomendacii-rossijskogo-obshhestva-rinologov-ostryj-rinosinusit/ Дата обращения 01.12.2023.

[11] Korkmazov MYu, Kazachkov EL, Lengina MA, et al. Cause-effect factors of rhinosinusitis poliposa development. Russian Rhinology. 2023;31(2):124–130. EDN: HHXGVS doi: 10.17116/rosrino202331021124

[12] Коркмазов М.Ю., Казачков Е.Л., Ленгина М.А., и др. Причинно-следственные факторы развития полипозного риносинусита // Российская ринология. 2023. Т. 31, № 2. С. 124–130. EDN: HHXGVS doi: 10.17116/rosrino202331021124

[13] Boiko NV, Stateshnaya PA, Gukasyan EL, Stagniev SD. Chronic rhinosinusitis in children. Russian Rhinology. 2021;29(3):161–166. EDN: JCDMPQ doi: 10.17116/rosrino202129031161

[14] Бойко Н.В., Статешная П.А., Гукасян Е.Л., Стагниев С.Д. Хронический риносинусит у детей // Российская ринология. 2021. Т. 29, № 3. С. 161–166. EDN: JCDMPQ doi: 10.17116/rosrino202129031161

[15] Snidvongs K, Sangubol M, Poachanukoon O. Pediatric versus adult chronic rhinosinusitis. Curr Allergy Asthma Rep. 2020;20(8):29. doi: 10.1007/s11882-020-00924-6

[16] Snidvongs K., Sangubol M., Poachanukoon O. Pediatric versus adult chronic rhinosinusitis // Curr Allergy Asthma Rep. 2020. Vol. 20, N 8. P. 29. doi: 10.1007/s11882-020-00924-6

[17] Di Cicco ME, Bizzoco F, Morelli E, et al. Nasal polyps in children: the early origins of a challenging adulthood condition. Children (Basel). 2021;8(11):997. doi: 10.3390/children8110997

[18] Di Cicco M.E., Bizzoco F., Morelli E., et al. Nasal polyps in children: the early origins of a challenging adulthood condition // Children (Basel). 2021. Vol. 8, N 11. P. 997. doi: 10.3390/children8110997

[19] Korkmazov MYu, Lengina MA, Korkmazov AM, et al. Treatment and prevention of various forms of laryngitis on the background of acute respiratory infections. Medical Council. 2022;16(8):79–87. EDN: NTPGJN doi: 10.21518/2079-701X-2022-16-8-79-87

[20] Коркмазов М.Ю., Ленгина М.А., Коркмазов А.М., и др. Лечение и профилактика различных форм ларингита на фоне острых респираторных инфекций // Медицинский совет. 2022. Т. 16, № 8. С. 79–87. EDN: NTPGJN doi: 10.21518/2079-701X-2022-16-8-79-87

[21] Lopatin AS, Azizov IS, Kozlov RS. Microbiome of nasal cavity and paranasal sinuses in norm and pathology. Part II. Russian Rhinology. 2021;29(2):81–89. EDN: HNCRMN doi: 10.17116/rosrino20212902181

[22] Лопатин А.С., Азизов И.С., Козлов Р.С. Микробиом полости носа и околоносовых пазух в норме и при патологии. Часть II // Российская ринология. 2021. Т. 29, № 2. С. 81–89. EDN: HNCRMN doi: 10.17116/rosrino20212902181

[23] Karpova EP, Gurov AV, Burlakova KY. Analysis of the mucous microbiome of the nasopharynx in children with chronic adenoiditis and otitis media of effusion. Pediatrics. Consilium Medicum. 2021;(1):39–45. EDN: OCIXAX doi: 10.26442/26586630.2021.1.200737

[24] Карпова Е.П., Гуров А.В., Бурлакова К.Ю. Анализ микробиома слизистой оболочки носоглотки у детей с хроническим аденоидитом и экссудативным средним отитом // Педиатрия. Consilium Medicum. 2021. № 1. С. 39–45. EDN: OCIXAX doi: 10.26442/26586630.2021.1.200737

[25] Krivopalov AA, Ryazansev SV, Shamkina PA. Complex homeopathic therapy of acute infectious rhinitis. Medical Council. 2019;(8):38–42. EDN: RLBDAU doi: 10.21518/2079-701X-2019-8-38-42

[26] Кривопалов А.А., Рязанцев С.В., Шамкина П.А. Комплексная терапия острого инфекционного ринита // Медицинский совет. 2019. № 8. С. 38–42. EDN: RLBDAU doi: 10.21518/2079-701X-2019-8-38-42

[27] Dubinets ID, Korkmazov MYu, Sinitsky AI, et al. Oxidative stress at the local and systemic level in chronic purulent otitis media. Medical Council. 2021;(18):148–156. EDN: UYYTRI doi: 10.21518/2079-701X-2021-18-148-156

[28] Дубинец И.Д., Коркмазов М.Ю., Синицкий А.И., и др. Окислительный стресс на локальном и системном уровне при хронических гнойных средних отитах // Медицинский совет. 2021. № 18. С. 148–156. EDN: UYYTRI doi: 10.21518/2079-701X-2021-18-148-156

[29] Alekseenko S, Karpischenko S, Barashkova S. Comparative analysis of mucociliary clearance and mucosal morphology using high-speed videomicroscopy in children with acute and chronic rhinosinusitis. Am J Rhinol Allergy. 2021;35(5):656–663. doi: 10.1177/1945892420988804

[30] Alekseenko S., Karpischenko S., Barashkova S. Comparative analysis of mucociliary clearance and mucosal morphology using high-speed videomicroscopy in children with acute and chronic rhinosinusitis // Am J Rhinol Allergy. 2021. Vol. 35, N 5. P. 656–663. doi: 10.1177/1945892420988804

[31] Russian Society of Rhinologists. Polyposis rhinosinusitis. Clinical recommendations. 2022. [Internet]. [cited: 2023 Oct 06]. Available from: http://rhinology.ru/wp-content/uploads/2022/10/ПРС-Клинические_рекомендации_финал.pdf

[32] Российское общество ринологов. Полипозный риносинусит. Клинические рекомендации. 2022 [интернет]. Дата обращения: 06.10.2023. Режим доступа: http://rhinology.ru/wp-content/uploads/2022/10/ПРС-Клинические_рекомендации_финал.pdf

[33] Korkmazov MYu, Zyryanova KS, Beloshangin AS. Evaluation of the clinical efficacy of a phytotherapeutic drug in the treatment and prevention of recurring acute rhinosinusitis in children of Chelyabinsk. Medical Council. 2016;(7):90–93. EDN: XTDDNX doi: 10.21518/2079-701X-2016-07-90-93

[34] Коркмазов М.Ю., Зырянова К.С., Белошангин А.С. Оценка клинической эффективности фитотерапевтического лекарственного препарата в лечении и профилактике рецидивов острых риносинуситов у детей г. Челябинска // Медицинский cовет. 2016. № 7. С. 90–93. EDN: XTDDNX doi: 10.21518/2079-701X-2016-07-90-93

[35] Schouwenaar EMM, Hellingman CA, Waterval JJ. Health-related quality of life after otologic surgical treatment for chronic otitis media: systematic review. Front Neurol. 2023;14:1268785. doi: 10.3389/fneur.2023.1268785

[36] Schouwenaar E.M.M., Hellingman C.A., Waterval J.J. Health-related quality of life after otologic surgical treatment for chronic otitis media: systematic review // Front Neurol. 2023. Vol. 14. P. 1268785. doi: 10.3389/fneur.2023.1268785

[37] Prajwal Gowda PR, Bai JS, Naik SM, et al. Evaluation of improvement in chronic rhinosinusitis after endoscopic sinus surgery using sino-nasal outcome Test-22 (SNOT22) Symptom Score. Indian J Otolaryngol Head Neck Surg. 2023;75(4):3337–3343. doi: 10.1007/s12070-023-03929-5

[38] Prajwal Gowda P.R., Bai J.S., Naik S.M., Abhilasha S. Evaluation of improvement in chronic rhinosinusitis after endoscopic sinus surgery using sino-nasal outcome Test-22 (SNOT22) Symptom Score // Indian J Otolaryngol Head Neck Surg. 2023. Vol. 75, N 4. P. 3337–3343. doi: 10.1007/s12070-023-03929-5

[39] Saibene AM, Rosso C, Pipolo C, et al. Endoscopic adenoidectomy: a systematic analysis of outcomes and complications in 1006 patients. Acta Otorhinolaryngol Ital. 2020;40(1):79–86. doi: 10.14639/0392-100X-N0150

[40] Saibene A.M., Rosso C., Pipolo C., et al. Endoscopic adenoidectomy: a systematic analysis of outcomes and complications in 1006 patients // Acta Otorhinolaryngol Ital. 2020. Vol. 40, N 1. P. 79–86. doi: 10.14639/0392-100X-N0150

RIGHTS & PERMISSIONS

Eco-Vector